Asupardo, Reahme M.

HRN: 21-37-93  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2022
CEFUROXIME 1.5GM (VIAL)
06/02/2022
06/02/2022
IV
1.5g
Loading Dose
Prophylaxis For CS
Waiting Final Action 
06/02/2022
CEFUROXIME 750MG (VIAL)
06/02/2022
06/08/2022
IV
750mg
Q8hours
Prophylaxis For CS
06/02/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/02/2022
06/04/2022
IV
500mg
Q8h X 6 Doses
S/P LTCS
Waiting Final Action 
06/04/2022
CEFUROXIME 500MG (TAB)
06/04/2022
06/08/2022
PO
500mg
BID
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: